Evidence map›Paper›PMID 38242130›Full record

ArticleMolecular cell2024

Acetyl-CoA production by Mediator-bound 2-ketoacid dehydrogenases boosts de novo histone acetylation and is regulated by nitric oxide.

Marta Russo, Francesco Gualdrini, Veronica Vallelonga, Elena Prosperini, Roberta Noberini, Silvia Pedretti, Carolina Borriero, Pierluigi Di Chiaro, Sara Polletti, Gabriele Imperato and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Energy metabolism in health and diseases.Signal transduction and targeted therapy · 2025
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Marta RussoDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy. Electronic address: marta.russo@ieo.it.
Francesco GualdriniDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy. Electronic address: francesco.gualdrini@ieo.it.
Veronica VallelongaDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Elena ProsperiniDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Roberta NoberiniDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Silvia PedrettiDiSFeB, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano 20133, Italy.
Carolina BorrieroDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Pierluigi Di ChiaroDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Sara PollettiDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Gabriele ImperatoDiSFeB, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano 20133, Italy.
Mattia MarendaDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Chiara GhirardiDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Fabio BedinDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Alessandro CuomoDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Simona RodighieroDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Tiziana BonaldiDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy; Department of Hematology and Hematology-Oncology (DIPO), Università degli Studi di Milano, Milano 20122, Italy.
Nico MitroDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy; DiSFeB, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano 20133, Italy.
Serena GhislettiDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy. Electronic address: serenamarialuisa.ghisletti@ieo.it.
Gioacchino NatoliDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy. Electronic address: gioacchino.natoli@ieo.it.
European Institute of Oncology · ITUniversity of Milan · IT

Funding

European Research Council 692789
6 · The paper itself

Abstract

Histone-modifying enzymes depend on the availability of cofactors, with acetyl-coenzyme A (CoA) being required for histone acetyltransferase (HAT) activity. The discovery that mitochondrial acyl-CoA-producing enzymes translocate to the nucleus suggests that high concentrations of locally synthesized metabolites may impact acylation of histones and other nuclear substrates, thereby controlling gene expression. Here, we show that 2-ketoacid dehydrogenases are stably associated with the Mediator complex, thus providing a local supply of acetyl-CoA and increasing the generation of hyper-acetylated histone tails. Nitric oxide (NO), which is produced in large amounts in lipopolysaccharide-stimulated macrophages, inhibited the activity of Mediator-associated 2-ketoacid dehydrogenases. Elevation of NO levels and the disruption of Mediator complex integrity both affected de novo histone acetylation within a shared set of genomic regions. Our findings indicate that the local supply of acetyl-CoA generated by 2-ketoacid dehydrogenases bound to Mediator is required to maximize acetylation of histone tails at sites of elevated HAT activity.

Indexed as

HistonesNitric OxideAcetylationAcetyl Coenzyme AMediator ComplexOxidoreductasesAcetyl Coenzyme AHistonesMediator ComplexNitric OxideOxidoreductases2-ketoacid dehydrogenasesacetylationchromatinlipopolysaccharideLPSLPS tolerancemacrophagesMediatornitric oxidepyruvate dehydrogenase

Identifiers

PMID38242130
PMCPMC7615796
OpenAlexW4391056199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.